Chronic Disease
Our work in Chronic Disease
-
Medicare Coverage of Weight Loss Drugs Could Save the U.S. Billions of Dollars
The new weight loss drugs work, and represent huge value in treating obesity. Even though they are expensive, broader access to them via Medicare would end up saving the U.S. money.
Categorized in -
Seminar Series – Boris Vabson
Boris Vabson is a research faculty member at Harvard Medical School. His academic research focuses on health insurance payment systems and markets. He is also a nonresident fellow at the USC-Schaeffer Center and a nonresident fellow in health policy at the American Enterprise Institute.
-
Seminar Series – Jorge Luis Garcia
Jorge Luis Garcia, PhD, is an applied micro-economist working at the intersection of labor and development economics. His work aims to quantify the economic fundamentals underlying the causal effects of major policies to inform their design and evaluation.
-
Response to Sen. Cassidy’s Request for Information on Improving Americans’ Access to Gene Therapies
Schaeffer experts submitted a comment letter responding to a request for information from stakeholders about improving access to cell and gene therapies for ultra-rare diseases.
Categorized in -
Assessment of the U.S. Food and Drug Administration’s Risk Evaluation and Mitigation Strategy (REMS) for Prasugrel (EFFIENT): A Narrative Review
The prasugrel REMS consisted of passive educational materials whose adequacy was evaluated using highly limited, one-time, cross-sectional surveys. The study’s assessment adds to evidence suggesting the importance of improving the quality and impact of the FDA’s post-approval activities to maximize drug safety.
Categorized in -
Biden’s Hepatitis C Initiative Needs Help from the Private Market
Instead of this massive nationalized program, the White House could make four administrative changes that would jump-start private-sector solutions in each state.
Categorized in -
Seminar Series – Anup Malani
Anup Malani is a legal scholar and economist. He is the Lee & Brena Freeman Professor at the University of Chicago Law School and a Research Associate at the National Bureau of Economic Research.
-
Want Lower Obesity Drug Costs? Medicare Holds the Key
Medicare coverage will catalyze market competition
Categorized in -
Adherence and Persistence of HIV Pre-Exposure Prophylaxis Use in the United States
Adherence to daily PrEP is high among commercially insured individuals but the majority still discontinue in the first year.
Categorized in -
Comments in Response to a CBO Call for New Research on Obesity
While there are significant data and methodological challenges to be overcome, there are better alternatives to simplistically extrapolating from the real-world data on AOM use that is currently available.
Categorized in